According to data provided by Zacks Research, Express Scripts Holding Company (NASDAQ:ESRX) has a consensus target price of $82.5 on the stock. Out of the polled analysts providing targets, the high is currently $94, while the low is resting at $71. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting Express Scripts Holding Company (NASDAQ:ESRX) to post a current quarter EPS of $1.32. This consensus number is compiled by Zacks Research. For the period ending on 2016-12-31, the company reported EPS for the quarter of $1.88. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was 0.53%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-04-24.
In terms of analyst ratings, Express Scripts Holding Company (NASDAQ:ESRX) has a current ABR of 2.37. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.
Wall Street sell-side research analysts covering Pfizer, Inc. (NYSE:PFE) shares have recently provided various price target projections on where the stock might be going. According to them, the stock is expected to reach $38.153 on a consensus level within the next year, according to Zacks. The most bullish estimate sees the stock reaching $52 while the most conservative estimate stand at $33.
Zacks also gives an average broker rating based on the sell-side recommendations from the analysts who cover Pfizer, Inc.. They give the company shares an ABR of 2.13. This is based on the 13 analysts taken into consideration by Zacks.
Earnings Estimates for Pfizer, Inc. (NYSE:PFE)
Currently, Wall Street is projecting that the firm will post $0.67 earnings per share. This consensus number is also derived from Zacks. For the most recent period which ended on 2016-12-31, Pfizer, Inc.'s EPS was reported as $0.47. This created a “surprise factor” -6% due to being $-0.03 apart from what Wall Street predicted. When actual numbers differ greatly from the consensus expectations, sharp movement in the stock price can often be seen in the hours or days following the report.
Investors will mark their calendars for 2017-05-02, the date when Pfizer, Inc. (NYSE:PFE) are expected to release their quarterly results.